DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0011849 | Diabetes Mellitus | SACM1L | 22908 | SAC1 like phosphatidylinositide phosphatase | Q9NTJ5 |
C0751955 | Brain Infarction | SACM1L | 22908 | SAC1 like phosphatidylinositide phosphatase | Q9NTJ5 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | SACM1L | 22908 | SAC1 like phosphatidylinositide phosphatase | Q9NTJ5 |
C0020538 | Hypertensive disease | SACM1L | 22908 | SAC1 like phosphatidylinositide phosphatase | Q9NTJ5 |
C1956346 | Coronary Artery Disease | SACM1L | 22908 | SAC1 like phosphatidylinositide phosphatase | Q9NTJ5 |
C1335177 | Ovarian Serous Adenocarcinoma | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0006142 | Malignant neoplasm of breast | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0376358 | Malignant neoplasm of prostate | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0006826 | Malignant Neoplasms | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0027651 | Neoplasms | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0086651 | Mucopolysaccharidosis, MPS-IV-A | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C1306459 | Primary malignant neoplasm | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0033975 | Psychotic Disorders | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0678222 | Breast Carcinoma | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0018213 | Graves Disease | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0005684 | Malignant neoplasm of urinary bladder | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0919267 | ovarian neoplasm | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0005586 | Bipolar Disorder | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0036341 | Schizophrenia | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0677886 | Epithelial ovarian cancer | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0699885 | Carcinoma of bladder | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C4721610 | Carcinoma, Ovarian Epithelial | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0005695 | Bladder Neoplasm | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C1140680 | Malignant neoplasm of ovary | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0600139 | Prostate carcinoma | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024